Agios Pharmaceuticals Scientists Present IDH1 Data at 2010 American Association for Cancer Research Meeting

WASHINGTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, a biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced multiple presentations at the American Association for Cancer Research (AACR) 101st Annual Meeting that highlight cancer metabolism as an approach to identify new ways to treat cancer, opening the potential for a new class of cancer drugs targeting metabolic enzymes.